Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2000)
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
22,861
Price
$72.85
Total Value
$1.67M
Shares Held After
13,930
% of Holdings
62.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
664
Price
$72.85
Total Value
$48.37K
Shares Held After
403
% of Holdings
62.2%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
27,879
Price
$72.85
Total Value
$2.03M
Shares Held After
16,988
% of Holdings
62.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
34,945
Price
$71.59
Total Value
$2.50M
Shares Held After
7,117
% of Holdings
83.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
180,651
Price
$71.59
Total Value
$12.93M
Shares Held After
36,791
% of Holdings
83.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
5,242
Price
$71.59
Total Value
$375.26K
Shares Held After
1,067
% of Holdings
83.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
220,302
Price
$71.59
Total Value
$15.77M
Shares Held After
44,867
% of Holdings
83.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
24,100
Price
$30.38
Total Value
$732.16K
Shares Held After
30,547
% of Holdings
44.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
24,100
Price
$30.38
Total Value
$732.16K
Shares Held After
11,223
% of Holdings
68.2%
Tempus AI, Inc. (TEM)
Doudna Jennifer A — Director
Shares
2,673
Price
$55.00
Total Value
$147.01K
Shares Held After
25,942
% of Holdings
9.3%
Tempus AI, Inc. (TEM)
Rogers James William — Chief Financial Officer
Shares
11,529
Price
$55.00
Total Value
$634.10K
Shares Held After
114,866
% of Holdings
9.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
510
Price
$2.56
Total Value
$1.31K
Shares Held After
2,393,902
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
145,880
Price
$2.48
Total Value
$361.78K
Shares Held After
2,393,392
% of Holdings
6.1%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
52,084
Price
$20.18
Total Value
$1.05M
Shares Held After
15,625
% of Holdings
76.9%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
5,000
Price
$20.50
Total Value
$102.50K
Shares Held After
406,775
% of Holdings
1.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.79K
Shares Held After
131,669
% of Holdings
1.7%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
2,300
Price
$35.12
Total Value
$80.77K
Shares Held After
56,450
% of Holdings
3.9%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
500,000
Price
$34.13
Total Value
$17.07M
Shares Held After
18,677,617
% of Holdings
2.6%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
3,400
Price
$35.09
Total Value
$119.31K
Shares Held After
65,631
% of Holdings
4.9%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
11,600
Price
$34.45
Total Value
$399.67K
Shares Held After
69,031
% of Holdings
14.4%
CG Oncology, Inc. (CGON)
Liu Brian Guan-Chyun — Director
Shares
371,085
Price
$66.87
Total Value
$24.81M
Shares Held After
1,886,236
% of Holdings
19.7%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
14,420
Price
$20.66
Total Value
$297.92K
Shares Held After
15,805
% of Holdings
47.7%
Immunome Inc. (IMNM)
Lechleider Robert — Chief Medical Officer
Shares
40,580
Price
$19.56
Total Value
$793.74K
Shares Held After
30,225
% of Holdings
57.3%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
1,373
Price
$5.70
Total Value
$7.83K
Shares Held After
3,619,622
% of Holdings
0.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
31,000
Price
$8.88
Total Value
$275.28K
Shares Held After
16,794,043
% of Holdings
0.2%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
17,200
Price
$29.08
Total Value
$500.18K
Shares Held After
9,581,734
% of Holdings
0.2%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
597,942
Price
$28.60
Total Value
$17.10M
Shares Held After
9,598,934
% of Holdings
5.9%
Passage BIO, Inc. (PASG)
Lynx1 Capital Management LP — 10% Owner
Shares
50,055
Price
$4.12
Total Value
$206.10K
Shares Held After
673,759
% of Holdings
7.4%
Beam Therapeutics Inc. (BEAM)
FMR LLC — 10% Owner
Shares
33,372
Price
$35.12
Total Value
$1.17M
Shares Held After
1,106,071
% of Holdings
2.9%
CalciMedica, Inc. (CALC)
Middleton Fred A — Director
Shares
248,972
Price
$0.80
Total Value
$200.00K
Shares Held After
1,063,272
% of Holdings
23.4%
Hongchang International Co., Ltd (HCIL)
Lin Zhenzhu — Director
Shares
9,998
Price
$0.11
Total Value
$1.07K
Shares Held After
62,243,084
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
10,000
Price
$87.14
Total Value
$871.40K
Shares Held After
97,994
% of Holdings
9.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,000
Price
$87.12
Total Value
$435.60K
Shares Held After
107,994
% of Holdings
4.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,127
Price
$3.00
Total Value
$6.38K
Shares Held After
115,018
% of Holdings
1.8%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
300
Price
$19.00
Total Value
$5.70K
Shares Held After
408,761
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
21,072
Price
$78.49
Total Value
$1.65M
Shares Held After
245,571
% of Holdings
7.9%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
300
Price
$19.00
Total Value
$5.70K
Shares Held After
166,359
% of Holdings
0.2%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
10,602
Price
$79.18
Total Value
$839.49K
Shares Held After
21,759
% of Holdings
32.8%
Krystal Biotech, Inc. (KRYS)
Thomas John Charles — EVP, General Counsel
Shares
1,000
Price
$347.27
Total Value
$347.27K
Shares Held After
0
% of Holdings
100.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
28,716
Price
$50.02
Total Value
$1.44M
Shares Held After
519,227
% of Holdings
5.2%
Viatris Inc (VTRS)
Campbell Paul — Interim Chief Financial Officer, Chief Accounting Officer and Corporate Controller
Shares
50,076
Price
$16.17
Total Value
$809.78K
Shares Held After
316,212
% of Holdings
13.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
100
Price
$87.00
Total Value
$8.70K
Shares Held After
60,137
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,337
Price
$86.51
Total Value
$980.76K
Shares Held After
60,137
% of Holdings
15.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
8,522
Price
$85.26
Total Value
$726.59K
Shares Held After
71,474
% of Holdings
10.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
419
Price
$86.39
Total Value
$36.20K
Shares Held After
60,137
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
582
Price
$85.24
Total Value
$49.61K
Shares Held After
60,556
% of Holdings
1.0%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
29,208
Price
$45.03
Total Value
$1.32M
Shares Held After
1,098,246
% of Holdings
2.6%
Definium Therapeutics, Inc. (DFTX)
Roberts Brandi — Chief Financial Officer
Shares
3,013
Price
$45.03
Total Value
$135.68K
Shares Held After
209,487
% of Holdings
1.4%
Definium Therapeutics, Inc. (DFTX)
Sullivan Mark — Chief Legal Officer
Shares
13,008
Price
$45.03
Total Value
$585.75K
Shares Held After
320,571
% of Holdings
3.9%
Greenland Mines Ltd (GRML)
El-Dada Riad Hussein — Director
Shares
175,000
Price
$0.23
Total Value
$40.55K
Shares Held After
175,000
% of Holdings
50.0%
Showing 101–150 of 2000 transactions (page 3 of 40)